Human pharmacokinetic profiling of the dipeptidyl peptidase‐IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling
This article is protected by copyright. All rights reserved.
Source: Biopharmaceutics and Drug Disposition - Category: Drugs & Pharmacology Authors: Yoshinobu Nakamaru, Chie Emoto, Makiko Shimizu, Hiroshi Yamazaki Tags: Original Paper Source Type: research
More News: Clinical Trials | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Ketoconazole | Liver | Study | Urology & Nephrology